New Perspectives on the Progression of Coronary Artery Calcification
and Patient Outcomes in Chronic Kidney Disease
Earn 1.5 hrs.
At the conclusion of the certified activity, participants should be able to do the following:
 | Discuss the epidemiology of hyperphosphatemia and cardiovascular calcification in patients with stage 5 chronic kidney disease (CKD) |
| Interpret the salient findings from recent clinical trials that investigated cardiovascular progression and mortality rates among patients with stage 5 CKD who were treated with various phosphate binders |
| Apply the process for the development of evidence-based best practices aimed at improving the quality of care for patients with stage 5 CKD. This ANNA Satellite symposium was suppored by an unrestricted educational grant from Fresenius Medical Care, Inc. |
No comments:
Post a Comment